Non-marketable Securities	3 Months Ended
Mar. 31, 2023
Non-marketable Securities
Non-marketable Securities	Note 4 Non-marketable Securities Non-marketable securities totaled $120.7 million and $89.0 million at March 31, 2023 and December 31, 2022, respectively, and included FRB stock, FHLB stock and other non-marketable securities. During the three months ended March 31, 2023 and 2022, purchases of non-marketable securities totaled $35.9 million and $4.0 million, respectively. Proceeds from non-marketable securities totaled $4.7 million and $60 thousand during three months ended March 31, 2023 and 2022, respectively. At March 31, 2023, the Company held $45.6 million of FHLB stock and $23.7 million of FRB stock for regulatory or debt facility purposes. At December 31, 2022, the Company held $20.3 million of FHLB stock and $18.1 million of FRB stock. Purchases of FHLB and FRB stock totaled $35.9 million and zero during the three months ended March 31, 2023 and 2022, respectively. These are restricted securities which, lacking a market, are carried at cost. There have been no identified events or changes in circumstances that may have an adverse effect on the investments carried at cost. At March 31, 2023, other non-marketable securities totaled $51.4 million and consisted of equity method investments totaling $22.4 million and convertible preferred stock without a readily determinable fair value totaling $29.0 million. At December 31, 2022, other non-marketable securities totaled $50.7 million and consisted of equity method investments totaling $21.7 million and convertible preferred stock without a readily determinable fair value totaling $29.0 million. During the three months ended March 31, 2023 and 2022, purchases of other non-marketable securities totaled zero and $4.0 million, respectively.

Non-marketable Securities

3 Months Ended

Mar. 31, 2023

Note 4 Non-marketable Securities

Non-marketable securities totaled $120.7 million and $89.0 million at March 31, 2023 and December 31, 2022, respectively, and included FRB stock, FHLB stock and other non-marketable securities. During the three months ended March 31, 2023 and 2022, purchases of non-marketable securities totaled $35.9 million and $4.0 million, respectively. Proceeds from non-marketable securities totaled $4.7 million and $60 thousand during three months ended March 31, 2023 and 2022, respectively.

At March 31, 2023, the Company held $45.6 million of FHLB stock and $23.7 million of FRB stock for regulatory or debt facility purposes. At December 31, 2022, the Company held $20.3 million of FHLB stock and $18.1 million of FRB stock. Purchases of FHLB and FRB stock totaled $35.9 million and zero during the three months ended March 31, 2023 and 2022, respectively. These are restricted securities which, lacking a market, are carried at cost. There have been no identified events or changes in circumstances that may have an adverse effect on the investments carried at cost.

At March 31, 2023, other non-marketable securities totaled $51.4 million and consisted of equity method investments totaling $22.4 million and convertible preferred stock without a readily determinable fair value totaling $29.0 million. At December 31, 2022, other non-marketable securities totaled $50.7 million and consisted of equity method investments totaling $21.7 million and convertible preferred stock without a readily determinable fair value totaling $29.0 million. During the three months ended March 31, 2023 and 2022, purchases of other non-marketable securities totaled zero and $4.0 million, respectively.